We are live on ! Find out more
AB

Amalgamated Bank Portfolio holdings

AUM $14.5B
1-Year Est. Return 44.3%
This Fund
S&P 500
This Quarter Est. Return
+8.23%
1 Year Est. Return
+44.3%
3 Year Est. Return
+131.76%
5 Year Est. Return
+175.18%
10 Year Est. Return
+715.35%
AUM
$12.5B
AUM Growth
+$9.81B
Cap. Flow
+$9.41B
Cap. Flow %
75.46%
Top 10 Hldgs %
19.2%
Holding
2,209
New
604
Increased
1,565
Reduced
9
Closed
28

Top Sells

Rank Stock Value
1
HUBS icon
HubSpot
HUBS
+$1.69M
2
IWV icon
iShares Russell 3000 ETF
IWV
+$1.66M
3
IPHI
INPHI CORPORATION
IPHI
+$1.59M
4
ZS icon
Zscaler
ZS
+$1.42M
5
RP
RealPage, Inc.
RP
+$1.36M

Sector Composition

Rank Sector Weight
1 Technology 21.27%
2 Financials 14.41%
3 Healthcare 12.88%
4 Consumer Discretionary 12.05%
5 Industrials 10.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRSP
2101
BrightSpire Capital
BRSP
$681M
$117K ﹤0.01%
+12,395
New +$114K
PAE
2102
DELISTED
PAE Incorporated Class A Common Stock
PAE
$117K ﹤0.01%
+13,112
New +$113K
ADV icon
2103
Advantage Solutions
ADV
$484M
$116K ﹤0.01%
+429
New +$132K
ASXC
2104
DELISTED
Asensus Surgical, Inc.
ASXC
$115K ﹤0.01%
+36,400
New +$91K
ARDX icon
2105
Ardelyx
ARDX
$1.24B
$114K ﹤0.01%
14,996
+4,484
+43% +$33.2K
VBIV
2106
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$114K ﹤0.01%
1,137
+290
+34% +$28.3K
ACCO icon
2107
Acco Brands
ACCO
$369M
$113K ﹤0.01%
+13,092
New +$116K
PGEN icon
2108
Precigen
PGEN
$1.93B
$113K ﹤0.01%
+17,328
New +$121K
SFL icon
2109
SFL Corp
SFL
$1.59B
$112K ﹤0.01%
+14,684
New +$120K
MGI
2110
DELISTED
MoneyGram International, Inc. New
MGI
$110K ﹤0.01%
+10,951
New +$92.4K
VTGN icon
2111
VistaGen Therapeutics
VTGN
$9.29M
$109K ﹤0.01%
+1,154
New +$85.5K
CLVS
2112
DELISTED
Clovis Oncology, Inc.
CLVS
$109K ﹤0.01%
18,811
+7,009
+59% +$41.1K
UEC icon
2113
Uranium Energy
UEC
$4.71B
$107K ﹤0.01%
40,082
+19,966
+99% +$60.1K
ATOS icon
2114
Atossa Therapeutics
ATOS
$22.8M
$106K ﹤0.01%
+1,122
New +$59.4K
MRC
2115
DELISTED
MRC Global
MRC
$106K ﹤0.01%
+11,308
New +$115K
TCRT icon
2116
Alaunos Therapeutics
TCRT
$4.74M
$105K ﹤0.01%
264
+76
+40% +$35.5K
CMRX
2117
DELISTED
Chimerix, Inc.
CMRX
$102K ﹤0.01%
+12,792
New +$106K
VIEW
2118
DELISTED
View, Inc. Class A Common Stock
VIEW
$101K ﹤0.01%
+198
New +$97.2K
SNR
2119
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$101K ﹤0.01%
+11,507
New +$79.2K
AKBA icon
2120
Akebia Therapeutics
AKBA
$327M
$98K ﹤0.01%
25,765
+3,381
+15% +$11.4K
TISI icon
2121
Team
TISI
$77.7M
$98K ﹤0.01%
+1,464
New +$133K
AMRX icon
2122
Amneal Pharmaceuticals
AMRX
$5.72B
$96K ﹤0.01%
18,831
+4,821
+34% +$27.4K
TTI icon
2123
TETRA Technologies
TTI
$1.23B
$95K ﹤0.01%
+21,819
New +$71.9K
VERU icon
2124
Veru
VERU
$36.1M
$89K ﹤0.01%
+1,107
New +$97.5K
PAVM icon
2125
PAVmed
PAVM
$33.9M
$87K ﹤0.01%
+30
New +$70.9K

Similar funds

Amalgamated Bank's Q2 2021 Portfolio in Review

As of Q2 2021, Amalgamated Bank held 2,209 positions worth $12.5B, up 368% from $2.67B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Amalgamated Bank deployed $9.41B of net new capital in Q2 2021, opening 604 new positions and adding to 1,565 existing holdings. Its largest new stake was Blackstone: 48,321 shares worth $4.69M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was HubSpot, an estimated $1.69M trimmed.

  • Amalgamated Bank's largest Q2 2021 buy was Blackstone: 48,321 shares worth $4.69M.
  • Amalgamated Bank added most to Apple in Q2 2021, an estimated $348M increase.
  • Amalgamated Bank's biggest Q2 2021 reduction was HubSpot, cutting an estimated $1.69M.
  • Amalgamated Bank fully exited INPHI CORPORATION in Q2 2021, selling an estimated $1.59M.
  • Amalgamated Bank's ten largest holdings make up 19% of its $12.5B portfolio in Q2 2021.
  • Amalgamated Bank opened 604 new positions and closed 28 in Q2 2021.
  • Amalgamated Bank's portfolio value rose 368% quarter-over-quarter to $12.5B.

Based on Amalgamated Bank's 13F filing for Q2 2021, filed 16 Aug 2021.